Effect of leukotriene receptor antagonist on cough variant asthma / 南方医科大学学报
Journal of Southern Medical University
;
(12): 694-696, 2009.
Artigo
em Chinês
| WPRIM
| ID: wpr-233708
ABSTRACT
<p><b>OBJECTIVE</b>To study the curative effect of leukotriene receptor antagonist on cough variant asthma (CVA).</p><p><b>METHODS</b>Sixty-four CVA patients received treatment with bricany and montelukas and 68 control patients had bricany treatment for 4 weeks. The recurrence rate was observed in the two groups during the follow-up for 6 months.</p><p><b>RESULTS</b>The remission time of two groups were 2.5-/+3.6 and 5.3-/+3.8 days in acute phase, respectively, showing a significant difference between them (P<0.05). The recurrence rate of the two groups within 6 months were 20.09% and 40.87%, respectively, showing also significantly differences (P<0.05).</p><p><b>CONCLUSION</b>Leukotriene receptor antagonist and bricany can effectively control CVA and significantly lower the short-term recurrence rate of CVA.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Farmacologia
/
Recidiva
/
Asma
/
Estudos de Casos e Controles
/
Seguimentos
/
Receptores de Leucotrienos
/
Antagonistas de Leucotrienos
/
Tosse
/
Usos Terapêuticos
/
Tratamento Farmacológico
Tipo de estudo:
Estudo observacional
/
Estudo prognóstico
Limite:
Adulto
/
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
Journal of Southern Medical University
Ano de publicação:
2009
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS